Li X, et al. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102–8.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chakraborty C, et al. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016–26.
CAS
PubMed
Google Scholar
Chakraborty C, et al. The 2019 novel coronavirus disease (COVID-19) pandemic: a zoonotic prospective. Asian Pac J Trop Med. 2020;13(6):242–6.
Article
CAS
Google Scholar
Chakraborty C, et al. Extensive partnership, collaboration, and teamwork is required to stop the COVID-19 outbreak. Arch Med Res. 2020;51(7):728–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Organization, W.H., Coronavirus disease 2019 (COVID-19): situation reports, weekly epidemiological update 2020.
Google Scholar
Long C, Zhong L. Genomics functional analysis and drug screening of SARS-CoV-2. Genes Dis. 2020;7.4:542-50.
Motieghader H, et al. mRNA–miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation. Mol BioSyst. 2017;13(10):2168–80.
Article
CAS
PubMed
Google Scholar
Habib MG, et al. mRNA and microRNA selection for breast cancer molecular subtype stratification using meta-heuristic based algorithms. Genomics. 2020;112.5:3207-17.
Leon-Icaza SA, Zeng M, Rosas-Taraco AG. microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines. ExRNA. 2019;1(1):1–1.
Article
PubMed Central
PubMed
Google Scholar
Abbott TR, et al. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell. 2020;181(4):865–876.e12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wei J, et al. Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection. bioRxiv. 2020:2020.06.16.155101. https://www.biorxiv.org/content/10.1101/2020.06.16.155101v1.abstract.
Gulshan S, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thor Soc. 2009;6.7:573-80.
Chakraborty C, Sharma AR. Consider TLR5 for new therapeutic development against COVID-19; 2020.
Book
Google Scholar
Saha A, et al. Tocilizumab: a therapeutic option for the treatment of cytokine storm syndrome in COVID-19. Arch Med Res. 2020;51(6):595–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhattacharya M, Sharma AR. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020;92(6):618–31.
Article
CAS
PubMed
Google Scholar
Blanco-Melo D, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181(5):1036–1045.e9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou Z, et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Cell Host Microbe. 2020;181(6):883–890.e2.
Article
CAS
Google Scholar
Xiong Y, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect. 2020;9(1):761–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prasad K, et al. Targeting hub genes and pathways of innate immune response in COVID-19: a network biology perspective. Int J Biol Macromol. 2020;163:1–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cava C, Bertoli G, Castiglioni I. In Silico discovery of candidate Drugs against Covid-19. Viruses. 2020;12(4):404.
Article
CAS
PubMed Central
Google Scholar
Sardar R, et al. Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis. bioRxiv. 2020:2020.03.21.001586. https://www.biorxiv.org/content/10.1101/2020.03.21.001586v1.abstract.
Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69–71.
Article
CAS
PubMed
Google Scholar
Murray MF, et al. COVID-19 outcomes and the human genome. Genet Med. 2020;22(7):1175–7.
Article
CAS
PubMed
Google Scholar
Bhatia R, Narang RK, Rawal RK. Drug Repurposing - A Promising Tool in Drug Discovery Against CoV-19. Biomed J Sci Tech Res. 2020;28(5):21913–5.
Google Scholar
Saha RP, et al. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020;11(1258). https://www.frontiersin.org/articles/10.3389/fphar.2020.01258/full.
Zhou Y, et al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6(1):14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stolfi P, et al. Designing a network proximity-based drug repurposing strategy for COVID-19. Front Cell Dev Biol. 2020;8(1021). https://www.frontiersin.org/articles/10.3389/fcell.2020.545089/full.
Zeng X, et al. deepDR: a network-based deep learning approach to in silico drug repositioning. Bioinformatics. 2019;35(24):5191–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheng F, et al. A genome-wide positioning systems network algorithm for in silico drug repurposing. Nat Commun. 2019;10(1):3476.
Article
PubMed
PubMed Central
CAS
Google Scholar
Stark C, et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34(Database issue):D535–9.
Article
CAS
PubMed
Google Scholar
Szklarczyk D, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018;47(D1):D607–13.
Article
PubMed Central
CAS
Google Scholar
Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang J, et al. ClusterViz: a Cytoscape APP for cluster analysis of biological network. IEEE/ACM Trans Comput Biol Bioinform. 2015;12(4):815–22.
Article
PubMed
Google Scholar
Li M, Wang J, Chen J. A Fast Agglomerate Algorithm for Mining Functional Modules in Protein Interaction Networks. In: 2008 International Conference on BioMedical Engineering and Informatics; 2008.
Google Scholar
Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12(8):697.
Article
CAS
PubMed
Google Scholar
Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
Article
PubMed
CAS
Google Scholar
Kanehisa M, et al. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004;32(Database issue):D277–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.
Article
PubMed
PubMed Central
Google Scholar
Lamb J, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929–35.
Article
CAS
PubMed
Google Scholar
Musa A, et al. A review of connectivity map and computational approaches in pharmacogenomics. Brief Bioinform. 2017;19(3):506–23.
PubMed Central
Google Scholar
Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
Article
PubMed
CAS
Google Scholar
Wagner AH, et al. DGIdb 2.0: mining clinically relevant drug–gene interactions. Nucleic Acids Res. 2016;44.D1:D1036-44.
Ge Y, et al. A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. bioRxiv. 2020:2020.03.11.986836. https://www.biorxiv.org/content/10.1101/2020.03.11.986836v1.abstract.
Bhattacharya M, et al. A SARS-CoV-2 vaccine candidate: In-silico cloning and validation. Inform Med Unlocked. 2020;20:100394.
Article
PubMed
PubMed Central
Google Scholar
Adhami M, et al. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer. Genomics. 2020;112(1):135–43.
Article
CAS
PubMed
Google Scholar
Fiscon G, et al. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLoS Comput Biol. 2021;17(2):e1008686.
Article
CAS
PubMed
PubMed Central
Google Scholar
Saha A, et al. Probable molecular mechanism of Remdesivir for the treatment of COVID-19: need to know more. Arch Med Res. 2020;51(6):585–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020;55(3):105923.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cortegiani A, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020;57:279–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Naksuk N, Lazar S, Peeraphatdit TB. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care. 2020;9(3):215–21.
Article
PubMed
Google Scholar
Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;277(5698):665–7.
Article
CAS
PubMed
Google Scholar
Al-Motawa M, et al. Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity – opportunity for repurposed chemotherapy of COVID-19 infection. bioRxiv. 2020:2020.04.07.029488. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581855/.
Landowski TH, et al. Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines. Cancer Res. 2005;65(9):3828–36.
Article
CAS
PubMed
Google Scholar
Xing J, et al. Reversal of infected host gene expression identifies repurposed drug candidates for COVID-19. bioRxiv. 2020:2020.04.07.030734. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217282.1/.
Loganathan T, et al. Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach. PeerJ. 2020;8:e9357.
Article
PubMed
PubMed Central
Google Scholar
Sinha S, et al. In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression. Mol Syst Biol. 2020;16(7):e9628.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jiménez-Alberto A, et al. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors. Comput Biol Chem. 2020;88:107325.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gordon DE, et al. A SARS-CoV-2-Human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv. 2020:2020.03.22.002386. https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3.
Priebe W, et al. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun. 1998;247(3):859–63.
Article
CAS
PubMed
Google Scholar